Cargando…

Acute iris vascular tuft hemorrhage treated successfully with intravitreal bevacizumab and pressure patching in a patient with branch retinal vein occlusion

PURPOSE: To report the presentation and management of active iris vascular tuft (IVT) hemorrhage and spontaneous hyphema in an eye with previous branch retinal vein occlusion (BRVO). OBSERVATIONS: A 74-year-old male with a history of BRVO in the left eye presented with spontaneous hyphema and blurre...

Descripción completa

Detalles Bibliográficos
Autores principales: Polski, Ashley, Kennedy, Brandon, Bair, Christopher, Simpson, Rachel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9792291/
https://www.ncbi.nlm.nih.gov/pubmed/36582845
http://dx.doi.org/10.1016/j.ajoc.2022.101780
_version_ 1784859601881006080
author Polski, Ashley
Kennedy, Brandon
Bair, Christopher
Simpson, Rachel
author_facet Polski, Ashley
Kennedy, Brandon
Bair, Christopher
Simpson, Rachel
author_sort Polski, Ashley
collection PubMed
description PURPOSE: To report the presentation and management of active iris vascular tuft (IVT) hemorrhage and spontaneous hyphema in an eye with previous branch retinal vein occlusion (BRVO). OBSERVATIONS: A 74-year-old male with a history of BRVO in the left eye presented with spontaneous hyphema and blurred vision. Clinical examination confirmed the presence of an actively bleeding IVT at the pupillary margin in the left eye. Sustained hemostasis was achieved following intravitreal bevacizumab injection and pressure patching of the eye. CONCLUSIONS AND IMPORTANCE: This is the first case report to demonstrate pressure patching as a non-invasive, effective method of achieving hemostasis in the acute setting of IVT hemorrhage. Intravitreal vascular endothelial growth factor antagonists such as bevacizumab may also be useful in decreasing the risk of IVT hemorrhage in eyes with chronic ischemia, although further investigation is warranted.
format Online
Article
Text
id pubmed-9792291
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-97922912022-12-28 Acute iris vascular tuft hemorrhage treated successfully with intravitreal bevacizumab and pressure patching in a patient with branch retinal vein occlusion Polski, Ashley Kennedy, Brandon Bair, Christopher Simpson, Rachel Am J Ophthalmol Case Rep Case Report PURPOSE: To report the presentation and management of active iris vascular tuft (IVT) hemorrhage and spontaneous hyphema in an eye with previous branch retinal vein occlusion (BRVO). OBSERVATIONS: A 74-year-old male with a history of BRVO in the left eye presented with spontaneous hyphema and blurred vision. Clinical examination confirmed the presence of an actively bleeding IVT at the pupillary margin in the left eye. Sustained hemostasis was achieved following intravitreal bevacizumab injection and pressure patching of the eye. CONCLUSIONS AND IMPORTANCE: This is the first case report to demonstrate pressure patching as a non-invasive, effective method of achieving hemostasis in the acute setting of IVT hemorrhage. Intravitreal vascular endothelial growth factor antagonists such as bevacizumab may also be useful in decreasing the risk of IVT hemorrhage in eyes with chronic ischemia, although further investigation is warranted. Elsevier 2022-12-13 /pmc/articles/PMC9792291/ /pubmed/36582845 http://dx.doi.org/10.1016/j.ajoc.2022.101780 Text en © 2022 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Case Report
Polski, Ashley
Kennedy, Brandon
Bair, Christopher
Simpson, Rachel
Acute iris vascular tuft hemorrhage treated successfully with intravitreal bevacizumab and pressure patching in a patient with branch retinal vein occlusion
title Acute iris vascular tuft hemorrhage treated successfully with intravitreal bevacizumab and pressure patching in a patient with branch retinal vein occlusion
title_full Acute iris vascular tuft hemorrhage treated successfully with intravitreal bevacizumab and pressure patching in a patient with branch retinal vein occlusion
title_fullStr Acute iris vascular tuft hemorrhage treated successfully with intravitreal bevacizumab and pressure patching in a patient with branch retinal vein occlusion
title_full_unstemmed Acute iris vascular tuft hemorrhage treated successfully with intravitreal bevacizumab and pressure patching in a patient with branch retinal vein occlusion
title_short Acute iris vascular tuft hemorrhage treated successfully with intravitreal bevacizumab and pressure patching in a patient with branch retinal vein occlusion
title_sort acute iris vascular tuft hemorrhage treated successfully with intravitreal bevacizumab and pressure patching in a patient with branch retinal vein occlusion
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9792291/
https://www.ncbi.nlm.nih.gov/pubmed/36582845
http://dx.doi.org/10.1016/j.ajoc.2022.101780
work_keys_str_mv AT polskiashley acuteirisvasculartufthemorrhagetreatedsuccessfullywithintravitrealbevacizumabandpressurepatchinginapatientwithbranchretinalveinocclusion
AT kennedybrandon acuteirisvasculartufthemorrhagetreatedsuccessfullywithintravitrealbevacizumabandpressurepatchinginapatientwithbranchretinalveinocclusion
AT bairchristopher acuteirisvasculartufthemorrhagetreatedsuccessfullywithintravitrealbevacizumabandpressurepatchinginapatientwithbranchretinalveinocclusion
AT simpsonrachel acuteirisvasculartufthemorrhagetreatedsuccessfullywithintravitrealbevacizumabandpressurepatchinginapatientwithbranchretinalveinocclusion